FDA Inspection
STAQ Pharma of Ohio, LLCSTAQ Pharma of Ohio, LLC – FDA Inspection, May 16, 2025
Record Details
This FDA Inspection record concerns STAQ Pharma of Ohio, LLC, with an inspection on May 16, 2025, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · 6a43a179-344d-40fb-9128-16c767182343
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1270348
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
- FDCA 503B(a)(10)(A)Drug product labels, fails to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of STAQ Pharma of Ohio, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 19, 2026 | Not classified | Cincinnati District Office | Drug Quality Assurance |
| October 4, 2023 | VAI | Drug Quality Assurance |
Other documents for STAQ Pharma of Ohio, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.